Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II dose-finding study of RF16001 for post-hemorrhoidectomy pain control
CTR20242858Phase 2Completed
- Sponsor
- Huili Technology
- Start
- Aug 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of RF16001, ropivacaine in postoperative pain, sponsored by Huili Technology. Started Aug 2024; status: completed.
02
Drugs
RF16001ropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on CTR20242858.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20242858.